Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

SightMD Welcomes Cataract & Glaucoma Specialist Dr. Aleksandra Michalik to New York’s Fastest Growing Ophthalmic Provider Group
  • USA - English


News provided by

SightMD

Nov 10, 2017, 08:00 ET

Share this article

Share toX

Share this article

Share toX

HAUPPAUGE, N.Y. (PRWEB) November 10, 2017 -- With a goal of giving patients greater access to more physicians in the convenience of their local neighborhoods, New York’s fastest growing ophthalmic provider group – SightMD – today announced the newest addition to their growing medical staff, Aleksandra Michalik, DO, according to noted eye surgeon, John Passarelli, MD, President of SightMD.

“At SightMD, we’re as passionate about the training and expertise of our physicians as we are about their commitment to the quality of care we provide our patients,” said Dr. Passarelli. “Having the opportunity to add Dr. Michalik to our surgical staff is rare because of her unique background and training, her commitment to personal patient care and her passion for improving ophthalmic care through advanced research. We could not be more excited to have her join our expanding medical staff here at SightMD.”

Dr. Michalik is a former analytical chemist at Estée Lauder who went on to earn her medical degree – with honors – at he New York College of Osteopathic Medicine of NYIT. She completed her ophthalmology residency at St. John’s Episcopal Hospital, Interfaith Medical Center, Brookdale University Hospital & Medical Center, and South Nassau Communities Hospital. She also attended Cornell University, where she graduated cum laude with an undergraduate degree in Biological Sciences.

Her love of glaucoma stems from her research experience with one of the world’s foremost glaucoma specialists, Dr. Jeffrey Freedman, who helped pioneer the use of implantable devices for the surgical treatment of glaucoma. Dr. Michalik completed her glaucoma fellowship at the University of Wisconsin (UW) School of Medicine and Public Health in Madison, WI, where she was involved in the ongoing multi-center study - Macular Pigment as a Glaucoma Risk Factor in CAREDS2 (Carotenoids in AgeRelated Eye Disease Study 2, an ancillary study to the Women’s Health Initiative) -evaluating the potential effect of increased carotenoid intake on lowering the risk and progression of glaucoma. While at UW, she was also involved in the Aerie Mercury 1 Trial, a randomized, multi-center study assessing the safety and efficacy of RoclatanTM (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%, a newly developed glaucoma medication awaiting FDA approval.

Dr. Michalik’s additional past research includes Glaucoma Treatment Adherence Barriers in an Afro-Caribbean Population of Low Socio-Economic Status, a study which assessed reasons for poor compliance with glaucoma treatment in the Brooklyn-based Afro-Caribbean community, a population with one of the highest rates and with some of the most advanced cases of glaucoma. Dr. Michalik, also, conducted a study with Dr. Jeffrey Freedman, Professor of Clinical Ophthalmology at SUNY Downstate Medical Center, assessing the new design of a surgical glaucoma implant: Supra-Tenon Capsule Placement of the Molteno 3 (GS) vs. the Molteno 3 (SS) Implants in Black Patients with Refractory Glaucoma: A Single-Surgeon Experience, which was presented at the 2017 American Glaucoma Society Annual Meeting. “I’ve always had a love of research and look forward to sharing my findings with my new colleagues at SightMD,” she said.

Dr. Michalik feels fortunate to have grown up on Long Island. “Joining the medical staff at SightMD is an absolute honor because of their tradition of eye excellence on Long Island,” said Dr. Michalik. “Having grown up on Long Island, I feel fortunate to be able to able to care for the friends, family members, and neighbors I grew up with.”

As a fellowship-trained glaucoma specialist with a secondary interest in cataract removal and lens implantation, Dr. Michalik feels her expertise is a perfect complement to their growing list of comprehensive eye care service. “There is no doubt I can contribute in a number of areas to the services being provided by SightMD,” she said. “I look forward to a long and lengthy career here on Long Island.”

Dr. Michalik is a proponent of continuing research and optimization of techniques in the field of ophthalmology. She has authored articles on glaucoma management to be published in peer-reviewed journals and has served as a reviewer of glaucoma research articles submitted for publication. She has lectured at leading medical centers and has presented numerous posters of her past research across the country. She is an active member of the American Glaucoma Society, American Academy of Ophthalmology and the American Osteopathic College of Ophthalmology & Otolaryngology.

As part of her past contributions to her community, Dr. Michalik has served as an emergency room volunteer for Good Samaritan Hospital, as well as, an Emergency Medical Services volunteer for the Massapequa Fire Department. In addition, Dr. Michalik has volunteered her time internationally at the Essalud Hospital in Cusco, Peru. She, also, volunteered her time in the malaria clinic in the Amazonian rainforest as an NIH research fellow, while she conducted ethnobiological research with indigenous tribes in the area, in hopes of discovering medicinal properties of the Amazonian flora and fauna.

Dr. Michalik is licensed in New York and Wisconsin. She is fluent in both English and Polish, and proficient in Spanish. When she is not volunteering at one of our local area medical centers, she enjoys travel, outdoor activities such as rockclimbing, water sports, dance, art, yoga, meditation, and cooking.

“Perhaps what I enjoy most about joining SightMD is that most of my colleagues are from right here in the greater Long Island and tri-state area,” said Dr. Michalik. “I look forward to helping continue their tradition of eye care excellence and caring for many of the friends, families, and neighbors we all grew up with.”

SightMD is New York’s fastest growing integrated ophthalmic provider group, offering patients the convenience of 23 locations from the east end of Long Island to Manhattan and access to over 50 ophthalmic surgeons and specialists. It was originally formed with the merger between North Shore Eye Care and Long Island Eye Surgical Care.

The doctors and staff of SightMD represent New York’s most established, full-service comprehensive eye care provider. SightMD is the official LASIK Provider of the New York Mets. Many of their physicians have been voted ‘TOP DOCTORS’ in the New York Metro Area by Castle Connolly and SightMD has earned ‘Best of Long Island’ honors for the past few years.

SightMD maintains offices in Amityville, Bay Shore, Brentwood, Deer Park, Garden City, Hampton Bays, Hauppauge, Hempstead, Holbrook, Huntington, Little Neck, Manhattan, Patchogue, Port Jefferson, Riverhead, Rockville Center, Sayville, Smithtown, Southampton, Southold, and West Islip. They specialize in cataract care, laser vision correction, glaucoma management, diabetic eye disease, ophthalmic plastic surgery, retinal care, and audiology. For more information about SightMD, please contact Heather Dall’Aste at 1-855-295-4144.

Heather Cuccia, SightMD, +1 855-295-4144 Ext: 136, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.